Risk of Major Adverse Cardiovascular Events With Dolutegravir Versus Efavirenz-Based Antiretroviral Therapy: Emulated Target Trials Using Routine, De-Identified Data From South Africa

Authors

Jennifer Anne Brown (ORCID: https://orcid.org/0000-0003-1874-6153)
Kwabena Asare (ORCID: https://orcid.org/0000-0002-5074-2315)
Shirley Collie (ORCID: https://orcid.org/0000-0003-4300-9649)
Johan van der Molen (ORCID: https://orcid.org/0009-0009-7290-7107)
Kwena Tlhaku (ORCID: https://orcid.org/0000-0002-2105-9146)
Xolani Masombuka
Claudia Pastellides
Nigel Garrett
Lara Lewis
Jienchi Dorward
Dave Jacobs
Christian Bottomley

Institutions

Desmond Tutu HIV Foundation (ZA)
Centre for the AIDS Programme of Research in South Africa (ZA)
University of Oxford (GB)
London School of Hygiene & Tropical Medicine (GB)
National Institute for Occupational Health (ZA)
University of KwaZulu-Natal (ZA)

Publication Details

Journal: Clinical Infectious Diseases
Published: 2026-03-03
DOI: https://doi.org/10.1093/cid/ciag155
Primary Topic: HIV-related health complications and treatments
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Risk of Major Adverse Cardiovascular Events With Dolutegravir Versus Efavirenz-Based Antiretroviral Therapy: Emulated Target Trials Using Routine, De-Identified Data From South Africa

Jennifer Anne Brown, Kwabena Asare, Shirley Collie, Johan van der Molen et al.

Mar 3, 2026

Clinical Infectious Diseases

HIV-related health complications and treatments

article

Risk of Major Adverse Cardiovascular Events With Dolutegravir Versus Efavirenz-Based Antiretroviral Therapy: Emulated Target Trials Using Routine, De-Identified Data From South Africa

Jennifer Anne Brown, Kwabena Asare, Shirley Collie, Johan van der Molen, Kwena Tlhaku, Xolani Masombuka, Claudia Pastellides, Nigel Garrett, Lara Lewis, Jienchi Dorward, Dave Jacobs, Christian Bottomley

March 3, 2026article en

Abstract

No abstract available for this paper.

Clinical Infectious Diseases

Desmond Tutu HIV Foundation (ZA), Centre for the AIDS Programme of Research in South Africa (ZA), University of Oxford (GB), London School of Hygiene & Tropical Medicine (GB), National Institute for Occupational Health (ZA), University of KwaZulu-Natal (ZA)

Good health and well-being

Openalex Percentile: Top 35%

HIV-related health complications and treatments

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Risk of Major Adverse Cardiovascular Events With Dolutegravir Versus Efavirenz-Based Antiretroviral Therapy: Emulated Target Trials Using Routine, De-Identified Data From South Africa — Jennifer Anne Brown, Kwabena Asare, et al. · Clinical Infectious Diseases (2026) | TGRS Research Map | TGRS